Published in Law and Health Weekly, October 3rd, 2009
A webcast of the presentation will be available live and for replay from the Seattle Genetics website, www.seattlegenetics.com, under the "investors & news" section. About Seattle Genetics Seattle Genetics is a clinical stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.